Wells Fargo
NUVB icon

Wells Fargo’s Nuvation Bio NUVB Stock Holding History

Wells Fargo’s Portfolio NUVB Stock Details NUVB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$815K Sell
189,910
-82,027
-30% -$457K ﹤0.01% 3856
2025
Q4 		$2.44M Buy
271,937
+82,595
+44% +$512K ﹤0.01% 3281
2025
Q3 		$701K Buy
189,342
+30,659
+19% +$83.5K ﹤0.01% 4065
2025
Q2 		$309K Buy
158,683
+49,861
+46% +$104K ﹤0.01% 4479
2025
Q1 		$192K Buy
108,822
+2,406
+2% +$5.48K ﹤0.01% 4736
2024
Q4 		$283K Buy
106,416
+23,178
+28% +$59.7K ﹤0.01% 4571
2024
Q3 		$191K Buy
83,238
+4,249
+5% +$13K ﹤0.01% 4610
2024
Q2 		$231K Buy
78,989
+27,506
+53% +$83.9K ﹤0.01% 4426
2024
Q1 		$187K Buy
51,483
+6,612
+15% +$12.7K ﹤0.01% 4508
2023
Q4 		$67.8K Buy
44,871
+8,858
+25% +$11.4K ﹤0.01% 5139
2023
Q3 		$48.3K Sell
36,013
-19,428
-35% -$32.3K ﹤0.01% 5192
2023
Q2 		$99.8K Buy
55,441
+34,603
+166% +$58.8K ﹤0.01% 5038
2023
Q1 		$34.6K Buy
+20,838
New +$42.2K ﹤0.01% 5367
2022
Q4 		– Sell
-442
Closed -$1K – 7633
2022
Q3 		$1K Sell
442
-1,029
-70% -$2.94K ﹤0.01% 6411
2022
Q2 		$5K Sell
1,471
-82,331
-98% -$359K ﹤0.01% 6012
2022
Q1 		$441K Sell
83,802
-52,953
-39% -$297K ﹤0.01% 4500
2021
Q4 		$1.16M Buy
136,755
+35,441
+35% +$326K ﹤0.01% 3997
2021
Q3 		$1.01M Buy
101,314
+48,114
+90% +$436K ﹤0.01% 4237
2021
Q2 		$496K Buy
53,200
+51,093
+2,425% +$583K ﹤0.01% 4614
2021
Q1 		$22K Buy
+2,107
New +$23.6K ﹤0.01% 6120

Other funds holding NUVB

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
DC
Decheng Capital Menlo Park, California $661M AUM 299.97% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
OFM
Omega Fund Management Boston, Massachusetts $163M AUM 107.06% 1-Year Est. Return
LCM
Laurion Capital Management New York $2.29B AUM 75.73% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
DFO
Duquesne Family Office New York $3.38B AUM 61.92% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Wells Fargo's NUVB Position: Q1 2026 in Review

Wells Fargo reduced its Nuvation Bio (NUVB) stake by 30% in Q1 2026, selling an estimated $457K and leaving 189,910 shares worth $815K. The position accounts for ﹤0.01% of the portfolio, ranked #3856.

Wells Fargo first reported a position in NUVB in Q1 2021 and has held it in 20 quarters since. The position peaked at $2.44M in Q4 2025. 231 funds tracked by Wall St. Rank hold NUVB as of Q1 2026.

  • Wells Fargo held 189,910 shares of Nuvation Bio worth $815K as of Q1 2026.
  • Wells Fargo sold 82,027 Nuvation Bio shares in Q1 2026, an estimated $457K.
  • Nuvation Bio made up ﹤0.01% of Wells Fargo's portfolio in Q1 2026, its #3856 holding.
  • Wells Fargo first reported a position in Nuvation Bio in Q1 2021 and has held it in 20 quarters since.
  • Wells Fargo's Nuvation Bio position peaked at $2.44M in Q4 2025.
  • 231 funds tracked by Wall St. Rank held Nuvation Bio as of Q1 2026.

Based on Wells Fargo's 13F filing for Q1 2026, filed 11 May 2026.